Bristlecone Advisors LLC Purchases New Position in Sana Biotechnology, Inc. (NASDAQ:SANA)
Bristlecone Advisors LLC purchased a new stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 50,000 shares of the company’s stock, valued at approximately $208,000. Other institutional investors and hedge funds have also recently […]
28 Oct 09:53 · The Markets Daily